Insights into the EU Joint Clinical Assessment (JCA) for Medical Devices and In Vitro Diagnostics

How is the EU Joint Clinical Assessment (JCA) changing the landscape for medical device and IVD manufacturers, and what does it mean for clinical evidence generation and market access?

During this ICEPS webinar, Rachel Hoad and Adam Ben Taieb from Lightning Health explored the evolving European Health Technology Assessment (HTA) framework, the practical implications of JCA, and the challenges manufacturers may face when preparing their evidence strategies.

From comparative clinical evidence to the role of the PICO framework and Joint Scientific Consultation (JSC), the session offered valuable perspectives on navigating this new European assessment environment.